EXK:NYSEEndeavour Silver Corporation Analysis
Data as of 2026-09-23 - not real-time
$9.24
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Endeavour Silver Corp. trades at $9.23, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it lost 9.8%. With RSI at 40.2 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $9.14 up to resistance at $11.65.
The shares look fair at 44.0 times earnings, though no sector average was available for comparison. Analyst price targets sit 67.8% above the current price. Revenue is growing at 139.4% on a 8.9% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 72.8%, a beta of 2.90 and a maximum drawdown of 47.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
The shares look fair at 44.0 times earnings, though no sector average was available for comparison. Analyst price targets sit 67.8% above the current price. Revenue is growing at 139.4% on a 8.9% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 72.8%, a beta of 2.90 and a maximum drawdown of 47.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Top Market Events
VANCOUVER, British Columbia, Aug. 23, 2026 GLOBE NEWSWIRE -- Endeavour Silver Corp. “Endeavour” or the...Die Endeavour-Silver-Aktie steht nach einer neuen Kreditlinie ueber 25 Mio.Endeavour Silver stock traded at USD 10.51 on September 22, 2026, up 3.75 percent. Guanacevi through
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 9.94
- MACD momentum is negative
- 30-day price change of -9.8%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 9.94
- Analyst targets imply +67.8% versus the current price
- 30-day volatility of 72.8%
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +67.8% versus the current price
- Revenue growth of +139.4%
- P/E ratio of 44.0
Key Metrics & Analysis
Financial Health
Revenue Growth139.40%
Profit Margin8.91%
P/E Ratio44.0
ROE10.58%
ROA10.13%
Debt/Equity34.84
P/B Ratio3.8
Op. Cash Flow$103.1M
Free Cash Flow$67.7M
Technical Analysis
TrendNeutral
RSI40.2
Support$9.14
Resistance$11.65
MA 20$10.52
MA 50$9.57
MA 200$9.94
MACDBearish
VolumeDecreasing
Fear & Greed Index94.39
Valuation
Fair Value$7.65
Target Price$15.50
Upside/Downside67.84%
GradeFair
TypeGrowth
Risk Assessment
Beta2.90
Volatility72.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.